Biotech giant Genentech is a paradox in many ways. It’s a big company, but still apparently a pleasant place to work -- a place where employees are treated with respect. It has a great suite of approved drugs, but there might be some gaps in the pipeline. And while it’s sometimes a Wall Street darling, it seems like the Streeters have their eyes on the wrong balls right now.
